세계의 심장혈관용 디지털 헬스 시장 규모, 점유율, 동향 분석 보고서 : 컴포넌트별, 최종 용도별, 지역별 전망 및 예측(2024-2031년)
Global Digital Health For Cardiovascular Market Size, Share & Trends Analysis Report By Component (Services, Software, and Hardware), By End-use, By Regional Outlook and Forecast, 2024 - 2031
상품코드:1709786
리서치사:KBV Research
발행일:2025년 03월
페이지 정보:영문 182 Pages
라이선스 & 가격 (부가세 별도)
한글목차
심혈관 디지털 건강 세계 시장 규모는 예측 기간 동안 21.9%의 연평균 복합 성장률(CAGR)로 성장하여 2031년까지 1,624억 달러에 달할 것으로 예측됩니다.
또한, 스마트워치, 피트니스 트래커, 웨어러블 심전도 모니터 등 웨어러블 기기는 지난 10년간 비약적인 성장을 거듭하며 예방적 심혈관 관리에 필수적인 도구로 부상하고 있습니다. 웨어러블 기기가 심장 건강에 변화를 가져온 대표적인 사례 중 하나는 심방세동(AFib)을 감지할 수 있는 능력으로, AFib는 불규칙하고 빈맥이 있는 심장 박동 리듬으로 심부전, 뇌졸중, 혈전 및 기타 심장 관련 합병증을 유발할 수 있습니다. 따라서 기술이 발전함에 따라 이러한 장치는 예방 심장학 및 만성 질환 관리에 더욱 중요한 역할을 할 것으로 예측됩니다.
또한, 코로나19 팬데믹은 초기에 순환기 디지털 헬스 시장에 몇 가지 도전을 안겨주었습니다. 초기에는 전 세계 의료 시스템이 코로나19 확진자 급증으로 인해 비응급 순환기 질환 치료에 대한 관심과 자원을 빼앗기면서 전 세계 의료 시스템이 압도당했습니다. 심장병 환자의 선택적 치료와 정기 검진은 종종 연기되거나 중단되어 표준 치료 및 모니터링 프로세스에 지장을 초래했습니다. 따라서 전염병은 전체 시장에 긍정적인 영향을 미쳤습니다.
그러나 웨어러블 심전도 모니터, AI 기반 진단, 원격 환자 모니터링 시스템과 같은 장치는 고가이기 때문에 많은 의료 서비스 제공업체와 환자가 이용할 수 없습니다. 이러한 기술은 지속적인 업데이트, 소프트웨어 통합, 클라우드 스토리지를 필요로 하는 경우가 많으며, 이는 운영 비용 증가로 이어집니다. 또한, 원격 의료 인프라를 구축하고 순환기 질환 환자를 위한 디지털 플랫폼을 유지하려면 사이버 보안, 규제 준수, 직원 교육에 대한 투자가 필요하며, 이는 의료 기관에 재정적 부담이 될 수 있습니다. 따라서 전략적 개입이 없다면, 디지털 헬스 툴의 높은 비용은 디지털화를 통한 순환기 건강관리 혁신에 큰 걸림돌이 될 수 있습니다.
부품 전망
시장은 구성 요소에 따라 소프트웨어, 하드웨어, 서비스로 분류됩니다. 하드웨어 부문은 2023년 시장에서 29%의 매출 점유율을 차지할 것으로 예측됩니다. 심전도 모니터, 심박수 센서가 장착된 스마트 워치, 이식형 심장 장치와 같은 장치에 대한 수요는 심장 질환의 유병률 증가와 예방 의료에 대한 관심 증가로 인해 증가하고 있습니다.
최종 용도 전망
최종 용도에 따라 시장은 환자, 의료 제공업체, 지불자 및 기타로 분류됩니다. 의료 제공업체 부문은 2023년 시장 매출 점유율의 21%를 차지할 것으로 예측됩니다. 병원, 진료소, 심장센터에서는 원격 의료 플랫폼, 원격 환자 모니터링 시스템, AI를 활용한 진단 솔루션과 같은 디지털 헬스 툴을 도입하여 적시에 정확한 심혈관 치료를 제공하기 위해 노력하고 있습니다.
지역 전망
지역별로는 북미, 유럽, 아시아태평양, LAMEA(라 메리아, 라 메리아) 등 4개 지역으로 시장을 분석했습니다. 아시아태평양은 2023년 시장 수익의 24%를 차지했습니다. 급속한 도시화, 식습관의 변화, 좌식 생활습관, 고혈압과 당뇨병의 높은 유병률로 인해 심장병 예방 및 관리를 위한 디지털 건강 솔루션에 대한 수요가 증가하고 있습니다.
목차
제1장 시장 범위와 조사 방법
시장의 정의
목적
시장 범위
세분화
조사 방법
제2장 시장 개관
주요 하이라이트
제3장 시장 개요
서론
개요
시장 구성과 시나리오
시장에 영향을 미치는 주요 요인
시장 성장 촉진요인
시장 성장 억제요인
시장 기회
시장이 해결해야 할 과제
제4장 경쟁 분석 - 세계
시장 점유율 분석, 2023년
심장혈관용 디지털 헬스 시장 전략
Porter의 Five Forces 분석
제5장 세계의 심장혈관용 디지털 헬스 시장 : 컴포넌트별
세계의 서비스 시장 : 지역별
세계의 소프트웨어 시장 : 지역별
세계의 하드웨어 시장 : 지역별
제6장 세계의 심장혈관용 디지털 헬스 시장 : 최종 용도별
세계의 환자 시장 : 지역별
세계의 의료 제공자 시장 : 지역별
세계의 지불자 시장 : 지역별
세계의 기타 최종 용도 시장 : 지역별
제7장 세계의 심장혈관용 디지털 헬스 시장 : 지역별
북미
북미 시장 : 국가별
미국
캐나다
멕시코
기타 북미
유럽
유럽 시장 : 국가별
독일
영국
프랑스
러시아
스페인
이탈리아
기타 유럽
아시아태평양
아시아태평양 시장 : 국가별
중국
일본
인도
한국
싱가포르
말레이시아
기타 아시아태평양
라틴아메리카/중동 및 아프리카
라틴아메리카/중동 및 아프리카 시장 : 국가별
브라질
아르헨티나
아랍에미리트(UAE)
사우디아라비아
남아프리카공화국
나이지리아
기타 라틴아메리카/중동 및 아프리카
제8장 기업 개요
Apple, Inc
Orange SA
Epic Systems Corporation
Siemens Healthineers AG(Siemens AG)
GE HealthCare Technologies, Inc
CardiAI Inc
Vistaai
Vizai
Cleerly, Inc
RSIP Vision Ltd
제9장 심장혈관용 디지털 헬스 시장 필 수요건
LSH
영문 목차
영문목차
The Global Digital Health For Cardiovascular Market size is expected to reach $162.40 billion by 2031, rising at a market growth of 21.9% CAGR during the forecast period.
The North America segment witnessed 37% revenue share in the market in 2023. The region benefits from the widespread use of remote patient monitoring (RPM) devices, telemedicine platforms, and wearable health technologies like the Apple Watch and KardiaMobile, which are FDA-cleared for detecting cardiovascular conditions such as atrial fibrillation.
The global prevalence of cardiovascular diseases (CVDs) has been rising at an alarming rate, making them the leading cause of death worldwide. In 2019, the World Health Organization (WHO) estimated that 17.9 million individuals perished from cardiovascular diseases (CVDs), which accounted for 32% of all global deaths. Heart attacks and strokes were responsible for 85% of these fatalities. Hence, the rising prevalence of cardiovascular diseases globally drives demand for digital health solutions.
Additionally, Wearable devices such as smartwatches, fitness trackers, and wearable ECG monitors have grown significantly over the past decade, emerging as vital tools in proactive cardiovascular care. One of the standout examples of wearables transforming heart health is their ability to detect atrial fibrillation (AFib). AFib is a cardiac rhythm that is irregular and frequently rapid, and it can result in heart failure, stroke, blood clots, and other heart-related complications. Thus, as technology advances, these devices are expected to become an even more integral part of preventive cardiology and chronic disease management.
Moreover, The COVID-19 pandemic initially posed several challenges to the digital health for cardiovascular market. In the early stages, healthcare systems worldwide were overwhelmed by COVID-19 cases, diverting attention and resources from non-emergency cardiovascular care. Elective procedures and routine check-ups for heart patients were often delayed or canceled, disrupting the standard treatment and monitoring processes. Thus, the pandemic had an overall positive impact on the market.
However, Many healthcare providers and patients are unable to access devices such as wearable cardiac monitors, AI-powered diagnostics, and remote patient monitoring systems due to their substantial cost. These technologies often require continuous updates, software integrations, and cloud storage, increasing operational expenses. Additionally, setting up telemedicine infrastructure and maintaining digital platforms for cardiovascular patients demands investment in cybersecurity, compliance with regulations, and staff training, which can financially overwhelm healthcare institutions. Hence, without strategic interventions, the high cost of digital health tools will continue to be a significant hurdle in transforming cardiovascular healthcare through digitalization.
Driving and Restraining Factors
Drivers * Rising Prevalence of Cardiovascular Diseases (CVDs)
Growing Adoption of Wearable Devices
Increased Demand for Remote Patient Monitoring (RPM)
Restraints * High Cost of Advanced Digital Health Tools
Limited Digital Literacy Among Patients and Healthcare Professionals
Opportunities * Technological Advancements in Telehealth
Increasing Proportion of the Aging Population
Challenges * Regulatory and Reimbursement Challenges
Significant Data Privacy and Security Concerns
Component Outlook
Based on component, the market is classified into software, hardware, and services. The hardware segment procured 29% revenue share in the market in 2023. The demand for devices such as ECG monitors, smartwatches with heart rate sensors, and implantable cardiac devices has increased as a result of the increasing prevalence of heart diseases as well as the growing emphasis on preventive care.
End-use Outlook
On the basis of end-use, the market is divided into patients, providers, payers, and others. The providers segment recorded 21% revenue share in the market in 2023. Hospitals, clinics, and cardiac centers are increasingly adopting digital health tools such as telemedicine platforms, remote patient monitoring systems, and AI-powered diagnostic solutions to provide timely and accurate cardiovascular care.
Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific segment garnered 24% revenue share in the market in 2023. Rapid urbanization, changing dietary habits, sedentary lifestyles, and high rates of hypertension and diabetes have increased the demand for digital health solutions targeting heart disease prevention and management.
Digital Health For Cardiovascular Market Coverage:
Report Attribute Details
Market size value in 2023 USD 33.95 Billion
Market size forecast in 2031 USD 162.40 Billion
Base Year 2023
Historical period 2020 to 2022
Forecast Period 2024 to 2031
Revenue Growth Rate CAGR of 21.9% from 2024 to 2031
Number of Pages 182
Tables 270
Report Coverage Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Market Share Analysis, Porter's 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives
Segments Covered Component, End-use, Region
Country Scope * North America (US, Canada, Mexico, and Rest of North America)
Europe (Germany, UK, France, Russia, Spain, Italy, and Rest of Europe)
Asia Pacific (Japan, China, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific)
LAMEA (Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA)
Companies Included Apple, Inc., Orange S.A., Epic Systems Corporation, Siemens Healthineers AG (Siemens AG), GE HealthCare Technologies, Inc.. CardiAI.Inc, Vista.ai (HeartVista, Inc.), Viz.ai, Inc., Cleerly, Inc., and RSIP Vision Ltd.
Recent Strategies Deployed in the Market
Feb-2025: Apple, Inc. launched the Apple Health Study to explore connections between physical and mental health, including cardiovascular and circulatory health. The study, conducted in partnership with Brigham and Women's Hospital, a Harvard Medical School affiliate, will leverage data from iPhones, Apple Watches, and AirPods over five years. This initiative builds on Apple's previous research, such as the Apple Heart Study, which contributed to health-monitoring features in its devices, further advancing digital health innovation.
Sep-2024: Cleerly, Inc. formed a partnership with Viz.ai, a U.S.-based AI healthcare company, to integrate AI-driven cardiovascular diagnostics into the Viz.ai One platform. This partnership aims to enhance early detection and care coordination for heart disease by leveraging Cleerly's FDA-approved AI software for analyzing coronary CTA images. By automating ischemia detection and plaque quantification, the collaboration seeks to improve patient outcomes through timely specialist referrals and personalized treatment planning.
Oct-2023: GE HealthCare came into partnership with Caption Health, a U.S.-based AI healthcare company, to integrate AI-driven Caption Guidance into its Venue Family point-of-care ultrasound systems. This AI-powered tool provides real-time guidance for cardiac ultrasound imaging, enabling a wider range of healthcare providers to conduct scans with diagnostic accuracy. The integration aims to enhance early heart disease detection, improve clinical decision-making, and expand ultrasound access in emergency and critical care settings.
Aug-2023: GE HealthCare Technologies, Inc. launched CardioVisio for Atrial Fibrillation, a digital clinical decision support tool designed to enhance precision care for AFib patients. This AI-powered solution integrates longitudinal patient data from multiple sources, providing guideline-directed insights to clinicians. By streamlining image interpretation and aiding treatment decisions, CardioVisio aims to improve patient outcomes and reduce misdiagnoses.
Aug-2022: GE HealthCare partnered with Nex Cubed, a U.S.-based startup accelerator, to launch the Edison Accelerator in Canada, selecting six AI-driven digital health startups to enhance medical imaging. This program aims to integrate AI into clinical workflows, improving diagnostics in areas like bone density screening, prostate cancer detection, and cardiac imaging.
List of Key Companies Profiled
Apple, Inc.
Orange S.A.
Epic Systems Corporation
Siemens Healthineers AG (Siemens AG)
GE HealthCare Technologies, Inc.
CardiAI.Inc
Vista.ai (HeartVista, Inc.)
Viz.ai, Inc.
Cleerly, Inc.
RSIP Vision Ltd.
Global Digital Health For Cardiovascular Market Report Segmentation
By Component
Services
Software
Hardware
By End-use
Patients
Providers
Payers
Other End-use
By Geography
North America
US
Canada
Mexico
Rest of North America
Europe
Germany
UK
France
Russia
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific
LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Digital Health For Cardiovascular Market, by Component
1.4.2 Global Digital Health For Cardiovascular Market, by End-use
1.4.3 Global Digital Health For Cardiovascular Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 Market Share Analysis, 2023
4.2 Strategies Deployed in Digital Health For Cardiovascular Market
4.3 Porter Five Forces Analysis
Chapter 5. Global Digital Health For Cardiovascular Market by Component
5.1 Global Services Market by Region
5.2 Global Software Market by Region
5.3 Global Hardware Market by Region
Chapter 6. Global Digital Health For Cardiovascular Market by End-use
6.1 Global Patients Market by Region
6.2 Global Providers Market by Region
6.3 Global Payers Market by Region
6.4 Global Other End-use Market by Region
Chapter 7. Global Digital Health For Cardiovascular Market by Region
7.1 North America Digital Health For Cardiovascular Market
7.1.1 North America Digital Health For Cardiovascular Market by Component
7.1.1.1 North America Services Market by Country
7.1.1.2 North America Software Market by Country
7.1.1.3 North America Hardware Market by Country
7.1.2 North America Digital Health For Cardiovascular Market by End-use
7.1.2.1 North America Patients Market by Country
7.1.2.2 North America Providers Market by Country
7.1.2.3 North America Payers Market by Country
7.1.2.4 North America Other End-use Market by Country
7.1.3 North America Digital Health For Cardiovascular Market by Country
7.1.3.1 US Digital Health For Cardiovascular Market
7.1.3.1.1 US Digital Health For Cardiovascular Market by Component
7.1.3.1.2 US Digital Health For Cardiovascular Market by End-use
7.1.3.2 Canada Digital Health For Cardiovascular Market
7.1.3.2.1 Canada Digital Health For Cardiovascular Market by Component
7.1.3.2.2 Canada Digital Health For Cardiovascular Market by End-use
7.1.3.3 Mexico Digital Health For Cardiovascular Market
7.1.3.3.1 Mexico Digital Health For Cardiovascular Market by Component
7.1.3.3.2 Mexico Digital Health For Cardiovascular Market by End-use
7.1.3.4 Rest of North America Digital Health For Cardiovascular Market
7.1.3.4.1 Rest of North America Digital Health For Cardiovascular Market by Component
7.1.3.4.2 Rest of North America Digital Health For Cardiovascular Market by End-use
7.2 Europe Digital Health For Cardiovascular Market
7.2.1 Europe Digital Health For Cardiovascular Market by Component
7.2.1.1 Europe Services Market by Country
7.2.1.2 Europe Software Market by Country
7.2.1.3 Europe Hardware Market by Country
7.2.2 Europe Digital Health For Cardiovascular Market by End-use
7.2.2.1 Europe Patients Market by Country
7.2.2.2 Europe Providers Market by Country
7.2.2.3 Europe Payers Market by Country
7.2.2.4 Europe Other End-use Market by Country
7.2.3 Europe Digital Health For Cardiovascular Market by Country
7.2.3.1 Germany Digital Health For Cardiovascular Market
7.2.3.1.1 Germany Digital Health For Cardiovascular Market by Component
7.2.3.1.2 Germany Digital Health For Cardiovascular Market by End-use
7.2.3.2 UK Digital Health For Cardiovascular Market
7.2.3.2.1 UK Digital Health For Cardiovascular Market by Component
7.2.3.2.2 UK Digital Health For Cardiovascular Market by End-use
7.2.3.3 France Digital Health For Cardiovascular Market
7.2.3.3.1 France Digital Health For Cardiovascular Market by Component
7.2.3.3.2 France Digital Health For Cardiovascular Market by End-use
7.2.3.4 Russia Digital Health For Cardiovascular Market
7.2.3.4.1 Russia Digital Health For Cardiovascular Market by Component
7.2.3.4.2 Russia Digital Health For Cardiovascular Market by End-use
7.2.3.5 Spain Digital Health For Cardiovascular Market
7.2.3.5.1 Spain Digital Health For Cardiovascular Market by Component
7.2.3.5.2 Spain Digital Health For Cardiovascular Market by End-use
7.2.3.6 Italy Digital Health For Cardiovascular Market
7.2.3.6.1 Italy Digital Health For Cardiovascular Market by Component
7.2.3.6.2 Italy Digital Health For Cardiovascular Market by End-use
7.2.3.7 Rest of Europe Digital Health For Cardiovascular Market
7.2.3.7.1 Rest of Europe Digital Health For Cardiovascular Market by Component
7.2.3.7.2 Rest of Europe Digital Health For Cardiovascular Market by End-use
7.3 Asia Pacific Digital Health For Cardiovascular Market
7.3.1 Asia Pacific Digital Health For Cardiovascular Market by Component
7.3.1.1 Asia Pacific Services Market by Country
7.3.1.2 Asia Pacific Software Market by Country
7.3.1.3 Asia Pacific Hardware Market by Country
7.3.2 Asia Pacific Digital Health For Cardiovascular Market by End-use
7.3.2.1 Asia Pacific Patients Market by Country
7.3.2.2 Asia Pacific Providers Market by Country
7.3.2.3 Asia Pacific Payers Market by Country
7.3.2.4 Asia Pacific Other End-use Market by Country
7.3.3 Asia Pacific Digital Health For Cardiovascular Market by Country
7.3.3.1 China Digital Health For Cardiovascular Market
7.3.3.1.1 China Digital Health For Cardiovascular Market by Component
7.3.3.1.2 China Digital Health For Cardiovascular Market by End-use
7.3.3.2 Japan Digital Health For Cardiovascular Market
7.3.3.2.1 Japan Digital Health For Cardiovascular Market by Component
7.3.3.2.2 Japan Digital Health For Cardiovascular Market by End-use
7.3.3.3 India Digital Health For Cardiovascular Market
7.3.3.3.1 India Digital Health For Cardiovascular Market by Component
7.3.3.3.2 India Digital Health For Cardiovascular Market by End-use
7.3.3.4 South Korea Digital Health For Cardiovascular Market
7.3.3.4.1 South Korea Digital Health For Cardiovascular Market by Component
7.3.3.4.2 South Korea Digital Health For Cardiovascular Market by End-use
7.3.3.5 Singapore Digital Health For Cardiovascular Market
7.3.3.5.1 Singapore Digital Health For Cardiovascular Market by Component
7.3.3.5.2 Singapore Digital Health For Cardiovascular Market by End-use
7.3.3.6 Malaysia Digital Health For Cardiovascular Market
7.3.3.6.1 Malaysia Digital Health For Cardiovascular Market by Component
7.3.3.6.2 Malaysia Digital Health For Cardiovascular Market by End-use
7.3.3.7 Rest of Asia Pacific Digital Health For Cardiovascular Market
7.3.3.7.1 Rest of Asia Pacific Digital Health For Cardiovascular Market by Component
7.3.3.7.2 Rest of Asia Pacific Digital Health For Cardiovascular Market by End-use
7.4 LAMEA Digital Health For Cardiovascular Market
7.4.1 LAMEA Digital Health For Cardiovascular Market by Component
7.4.1.1 LAMEA Services Market by Country
7.4.1.2 LAMEA Software Market by Country
7.4.1.3 LAMEA Hardware Market by Country
7.4.2 LAMEA Digital Health For Cardiovascular Market by End-use
7.4.2.1 LAMEA Patients Market by Country
7.4.2.2 LAMEA Providers Market by Country
7.4.2.3 LAMEA Payers Market by Country
7.4.2.4 LAMEA Other End-use Market by Country
7.4.3 LAMEA Digital Health For Cardiovascular Market by Country
7.4.3.1 Brazil Digital Health For Cardiovascular Market
7.4.3.1.1 Brazil Digital Health For Cardiovascular Market by Component
7.4.3.1.2 Brazil Digital Health For Cardiovascular Market by End-use
7.4.3.2 Argentina Digital Health For Cardiovascular Market
7.4.3.2.1 Argentina Digital Health For Cardiovascular Market by Component
7.4.3.2.2 Argentina Digital Health For Cardiovascular Market by End-use
7.4.3.3 UAE Digital Health For Cardiovascular Market
7.4.3.3.1 UAE Digital Health For Cardiovascular Market by Component
7.4.3.3.2 UAE Digital Health For Cardiovascular Market by End-use
7.4.3.4 Saudi Arabia Digital Health For Cardiovascular Market
7.4.3.4.1 Saudi Arabia Digital Health For Cardiovascular Market by Component
7.4.3.4.2 Saudi Arabia Digital Health For Cardiovascular Market by End-use
7.4.3.5 South Africa Digital Health For Cardiovascular Market
7.4.3.5.1 South Africa Digital Health For Cardiovascular Market by Component
7.4.3.5.2 South Africa Digital Health For Cardiovascular Market by End-use
7.4.3.6 Nigeria Digital Health For Cardiovascular Market
7.4.3.6.1 Nigeria Digital Health For Cardiovascular Market by Component
7.4.3.6.2 Nigeria Digital Health For Cardiovascular Market by End-use
7.4.3.7 Rest of LAMEA Digital Health For Cardiovascular Market
7.4.3.7.1 Rest of LAMEA Digital Health For Cardiovascular Market by Component
7.4.3.7.2 Rest of LAMEA Digital Health For Cardiovascular Market by End-use
Chapter 8. Company Profiles
8.1 Apple, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.6 SWOT Analysis
8.2 Orange S.A.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental Analysis
8.3 Epic Systems Corporation
8.3.1 Company Overview
8.3.2 SWOT Analysis
8.4 Siemens Healthineers AG (Siemens AG)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.4.6 SWOT Analysis
8.5 GE HealthCare Technologies, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.6 SWOT Analysis
8.6 CardiAI Inc.
8.6.1 Company Overview
8.7 Vista.ai
8.7.1 Company Overview
8.8 Viz.ai
8.8.1 Company Overview
8.9 Cleerly, Inc.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.10. RSIP Vision Ltd.
8.10.1 Company Overview
Chapter 9. Winning Imperatives of Digital Health For Cardiovascular Market